RSNA’s Quantitative Imaging Biomarkers Alliance provides a forum for stakeholders to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time. Stakeholders include the clinical research community, imaging equipment manufacturers, the pharmaceutical industry, government, and medical informatics companies.
Efficient and valid methods for quantifying biomedical imaging results are required for optimal patient care, clinical research, and new therapy development. QIBA accelerates the development and adoption of hardware and software standards needed to achieve these results.
QIBA follows a defined, coordinated process for solutions development and adoption: